AR067027A1 - Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a. - Google Patents
Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.Info
- Publication number
- AR067027A1 AR067027A1 ARP080102573A ARP080102573A AR067027A1 AR 067027 A1 AR067027 A1 AR 067027A1 AR P080102573 A ARP080102573 A AR P080102573A AR P080102573 A ARP080102573 A AR P080102573A AR 067027 A1 AR067027 A1 AR 067027A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heterocycloalkyl
- heteroaryl
- aryl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94487907P | 2007-06-19 | 2007-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR067027A1 true AR067027A1 (es) | 2009-09-30 |
Family
ID=40084145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102573A AR067027A1 (es) | 2007-06-19 | 2008-06-17 | Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080318943A1 (ko) |
EP (1) | EP2176263A2 (ko) |
JP (1) | JP2010530405A (ko) |
KR (1) | KR20100039339A (ko) |
CN (1) | CN101778849A (ko) |
AR (1) | AR067027A1 (ko) |
AU (1) | AU2008264984A1 (ko) |
BR (1) | BRPI0813379A2 (ko) |
CA (1) | CA2691237A1 (ko) |
CL (1) | CL2008001838A1 (ko) |
MX (1) | MX2009013885A (ko) |
PE (1) | PE20090693A1 (ko) |
TW (1) | TW200904817A (ko) |
UY (1) | UY31159A1 (ko) |
WO (1) | WO2008155572A2 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2751705T3 (es) * | 2009-10-26 | 2020-04-01 | Signal Pharm Llc | Métodos de síntesis y purificación de compuestos heteroarilo |
WO2014127214A1 (en) | 2013-02-15 | 2014-08-21 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
AU2014219024B2 (en) | 2013-02-20 | 2018-04-05 | KALA BIO, Inc. | Therapeutic compounds and uses thereof |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
AU2014342042B2 (en) | 2013-11-01 | 2017-08-17 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
GB201322334D0 (en) | 2013-12-17 | 2014-01-29 | Agency Science Tech & Res | Maleimide derivatives as modulators of WNT pathway |
TWI758241B (zh) | 2015-01-13 | 2022-03-21 | 日商日產化學工業股份有限公司 | 反應混合物中之錫化合物之處理方法 |
CA3036336A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
BR112019004463A2 (pt) | 2016-09-08 | 2019-05-28 | Kala Pharmaceuticals Inc | formas cristalinas de compostos terapêuticos, seus processos de obtenção e seus métodos de uso |
CN108863917A (zh) * | 2017-05-16 | 2018-11-23 | 穆云 | 一种2,5-二甲氧基吡啶的制备方法 |
EP3645509B1 (en) * | 2017-06-27 | 2021-03-24 | Bayer Aktiengesellschaft | Method for preparing substituted 4-aminoindane derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ190834A (en) * | 1979-01-22 | 1984-07-06 | Lilly Co Eli | Trans-dl-5-(alkyl or allyl)-4,4a,5,6,7,8,8a,9-octahydro-21 + pyrrolo(3,4-g)quinolines, |
GB8610980D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Heterocyclic fused tricyclic compounds |
US5240934A (en) * | 1990-10-19 | 1993-08-31 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
US5190951A (en) * | 1990-10-19 | 1993-03-02 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
RU2257385C2 (ru) * | 2003-08-26 | 2005-07-27 | ООО "Исследовательский институт химического разнообразия" | 1,3-диоксо -2,3-дигидро-1h-пирроло[3,4-c]хинолины (варианты), фармацевтические композиции (варианты), способ их получения (варианты) и способы лечения (варианты) |
-
2008
- 2008-06-17 AR ARP080102573A patent/AR067027A1/es unknown
- 2008-06-17 TW TW097122558A patent/TW200904817A/zh unknown
- 2008-06-18 MX MX2009013885A patent/MX2009013885A/es not_active Application Discontinuation
- 2008-06-18 JP JP2010512776A patent/JP2010530405A/ja active Pending
- 2008-06-18 CN CN200880103096A patent/CN101778849A/zh active Pending
- 2008-06-18 CA CA2691237A patent/CA2691237A1/en not_active Abandoned
- 2008-06-18 UY UY31159A patent/UY31159A1/es unknown
- 2008-06-18 EP EP08806633A patent/EP2176263A2/en not_active Withdrawn
- 2008-06-18 BR BRPI0813379-4A2A patent/BRPI0813379A2/pt not_active Application Discontinuation
- 2008-06-18 US US12/141,190 patent/US20080318943A1/en not_active Abandoned
- 2008-06-18 WO PCT/GB2008/050456 patent/WO2008155572A2/en active Application Filing
- 2008-06-18 KR KR1020107001091A patent/KR20100039339A/ko not_active Application Discontinuation
- 2008-06-18 AU AU2008264984A patent/AU2008264984A1/en not_active Abandoned
- 2008-06-19 PE PE2008001052A patent/PE20090693A1/es not_active Application Discontinuation
- 2008-06-19 CL CL2008001838A patent/CL2008001838A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2008001838A1 (es) | 2009-03-06 |
WO2008155572A2 (en) | 2008-12-24 |
EP2176263A2 (en) | 2010-04-21 |
BRPI0813379A2 (pt) | 2014-12-30 |
AU2008264984A1 (en) | 2008-12-24 |
JP2010530405A (ja) | 2010-09-09 |
KR20100039339A (ko) | 2010-04-15 |
PE20090693A1 (es) | 2009-07-17 |
UY31159A1 (es) | 2009-01-30 |
CA2691237A1 (en) | 2008-12-24 |
CN101778849A (zh) | 2010-07-14 |
TW200904817A (en) | 2009-02-01 |
US20080318943A1 (en) | 2008-12-25 |
MX2009013885A (es) | 2010-01-27 |
WO2008155572A3 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR067027A1 (es) | Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a. | |
AR056892A1 (es) | Derivados de cinolin-3-carboxamida, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la modulacion del receptor gabaa | |
AU2021282491B2 (en) | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | |
AR077130A1 (es) | Inhibidores de la replicacion de los virus de influenza | |
HRP20210344T1 (hr) | Pripravci i postupci liječenja poremećaja cns | |
AR073684A1 (es) | Derivados de bencimidazol | |
AR072086A1 (es) | Compuestos triciclicos, metodos para su preparacion, composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por la actividad de las proteinas quinasas. | |
HRP20191163T1 (hr) | Heteroaromatski spojevi i njihova upotreba kao dopaminskih liganda d1 | |
AR069524A1 (es) | Derivados de isoxazolo - pirazina, un procedimiento para la preparacion del compuesto, medicamento en base al compuesto y uso del compuesto para preparar un medicamento | |
AR048789A1 (es) | Derivados de oxazol y sus composiciones como moduladores de receptor activado de proliferador de peroxisoma (ppar) | |
AR043998A1 (es) | Acidos fenoxiaceticos | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
AR085316A1 (es) | Derivados de pirrolo[2,3-b]piridina, utiles para la modulacion de quinasas | |
AR083358A1 (es) | Compuestos de furo[3,2-d]pirimidina | |
AR050279A1 (es) | Indazoles como moduladores de lxr utiles en la preparacion de medicamentos pata el tratamiento de enfermedades cardiovasculares y mediadas por th1 y composiciones farmaceuticas que los contienen como principio activo. | |
AR064299A1 (es) | Derivados de sulfonil-fenil-2h- [1,2,4] oxadiazol-5-ona procesos para su preparacion y su uso como agentes farmaceuticos | |
AR045470A1 (es) | Derivados de acido fenoxiacetico | |
AR049521A1 (es) | Derivados de pirrazol - pirimidina | |
AR054208A1 (es) | Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediarios | |
BR112012020607A2 (pt) | derivados de piperidina, processo para preparação do mesmo, medicamento e uso dos referidos derivados | |
AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
AR116474A1 (es) | DERIVADOS DEL ÁCIDO 6,7-DIHIDRO-2H-BENZOFURO[2,3-a]QUINOLIZIN-3-CARBOXÍLICO COMO AGENTES ANTIVIRALES PARA EL TRATAMIENTO O PREVENCIÓN DE UNA INFECCIÓN POR HBV | |
AR084730A1 (es) | Ligandos heterociclicos nitrogenados de receptores sigma utiles para el tratamiento de dolor por cancer de huesos | |
AR056470A1 (es) | Sulfonamidos n- ciclicos puenteados inhibidores de gamma secretasa | |
AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |